Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.
Description
Natrelle 133S Tissue Expanders
Indication and Usage
The Natrelle® 133S Tissue Expander can be used for breast reconstruction following mastectomy, treatment of underdeveloped breasts, and treatment of soft tissue deformities. The expander is intended for temporary subcutaneous or submuscular implantation and is not intended for use beyond six months.
Approval History
FDA approved 2026
Includes history for all formulations of adalimumab
January 16, 2026
(Type 2 New Active Ingredient and Type 4 New Combination)
Frequently Asked Questions
How much does Humira cost without insurance?
J
John Doe
New York, US
Products:
Humira
Humira
J
John Doe
New York, US
Products:
Humira
Humira
Signup or Login to view Reps
You must have an account to view Reps detail
Already have an account? Login
There isn't any reviews posted yet. You can be the first to review the product
